Absci to Participate in the TD Cowen 45th Annual Health Care Conference
Absci (Nasdaq: ABSI), a data-first generative AI drug creation company, has announced its participation in the TD Cowen 45th Annual Health Care Conference in Boston, MA. The company's management will engage in a fireside chat on Monday, March 3rd at 3:10 p.m. Eastern Time (12:10 p.m. Pacific Time).
Interested parties can access both live and archived webcasts of the presentation through Absci's investor relations website at investors.absci.com.
Absci (Nasdaq: ABSI), un'azienda che utilizza l'IA generativa orientata ai dati per la creazione di farmaci, ha annunciato la sua partecipazione al 45° Congresso Annuale sulla Salute di TD Cowen a Boston, MA. La direzione dell'azienda parteciperà a una chiacchierata informale lunedì 3 marzo alle 15:10 ora orientale (12:10 ora del Pacifico).
Le parti interessate possono accedere sia alle dirette che alle registrazioni delle presentazioni attraverso il sito web delle relazioni con gli investitori di Absci all'indirizzo investors.absci.com.
Absci (Nasdaq: ABSI), una empresa de creación de fármacos basada en IA generativa y orientada a los datos, ha anunciado su participación en la 45ª Conferencia Anual de Salud de TD Cowen en Boston, MA. La dirección de la empresa participará en una charla informal el lunes 3 de marzo a las 3:10 p.m. hora del Este (12:10 p.m. hora del Pacífico).
Las partes interesadas pueden acceder tanto a las transmisiones en vivo como a las grabaciones de la presentación a través del sitio web de relaciones con inversores de Absci en investors.absci.com.
Absci (Nasdaq: ABSI), 데이터 중심의 생성적 AI 약물 개발 회사가 TD Cowen 제45회 연례 건강 관리 회의에 참여한다고 발표했습니다. 회사 경영진은 3월 3일 월요일 오후 3시 10분 동부 표준시 (태평양 표준시 오후 12시 10분)에 화상 대화에 참여할 예정입니다.
관심 있는 분들은 Absci의 투자자 관계 웹사이트인 investors.absci.com을 통해 발표의 실시간 및 아카이브 웹캐스트에 접근할 수 있습니다.
Absci (Nasdaq: ABSI), une entreprise de création de médicaments utilisant l'IA générative axée sur les données, a annoncé sa participation à la 45ème Conférence Annuelle sur la Santé de TD Cowen à Boston, MA. La direction de l'entreprise participera à une discussion informelle le lundi 3 mars à 15h10 heure de l'Est (12h10 heure du Pacifique).
Les parties intéressées peuvent accéder aux webcasts en direct et archivés de la présentation via le site web des relations investisseurs d'Absci à l'adresse investors.absci.com.
Absci (Nasdaq: ABSI), ein datengestütztes Unternehmen für generative KI in der Arzneimittelentwicklung, hat seine Teilnahme an der 45. Jahrestagung zur Gesundheitsversorgung von TD Cowen in Boston, MA, bekannt gegeben. Das Management des Unternehmens wird am Montag, den 3. März um 15:10 Uhr Eastern Time (12:10 Uhr Pazifische Zeit) an einem Gespräch teilnehmen.
Interessierte Parteien können sowohl die Live- als auch die aufgezeichneten Webcasts der Präsentation über die Investor-Relations-Website von Absci unter investors.absci.com abrufen.
- None.
- None.
VANCOUVER, Wash. and NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming TD Cowen 45th Annual Health Care Conference in Boston, MA.
Absci management is scheduled to participate in a fireside chat on Monday, March 3rd at 3:10 p.m. Eastern Time (12:10 p.m. Pacific Time). Interested parties may access a live and archived webcast on the company’s investor relations website at: investors.absci.com.
About Absci
Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed candidates to wet lab-validated candidates in as little as six weeks. Absci’s headquarters is in Vancouver, WA, with our AI Research Lab in New York City and an Innovation Center in Zug, Switzerland. Visit www.absci.com and follow us on LinkedIn (@absci), X (Twitter) (@Abscibio), and YouTube.
Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com
Media Contact
press@absci.com
FAQ
When is Absci (ABSI) presenting at the TD Cowen Health Care Conference 2025?
How can investors watch Absci's (ABSI) presentation at the TD Cowen conference?
What type of presentation will Absci (ABSI) give at the TD Cowen conference?
Where is the TD Cowen Health Care Conference featuring Absci (ABSI) being held?
